Frontlight ResearchEarly access
Trial site
Tokai University Hospital
- 12running trials
- 4closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Chronic kidney disease1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Diffuse large B-cell lymphoma1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 312 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting9 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Gilead Sciences2 trials
- Incyte Biosciences Japan GK2 trials
- Biotronik SE & Co. KG1 trial
- Boehringer Ingelheim1 trial
- and 6 more
Running trials
Recruiting
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Recruiting
Completed
Terminated
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 15 Nov 2026